Moneycontrol PRO
Open App

The wait for Sun Pharma to rise gets longer

May 28, 2020 / 12:09 PM IST
The wait for Sun Pharma to rise gets longer

Abbott India | Current share price Rs 16,700, trading 10.06 percent below its 52-week high of Rs 18,569

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights - Diversified pharma major with strong interest in the US specialty business - Q4 sales helped by domestic market and EM performance - Legal and regulatory hurdles are key drags, near term focus remains on R&D - Ramp-up of US business a key monitorable to get constructive India’s largest pharma company Sun Pharma (CMP: Rs 450 Market cap: Rs 108,102 crore) has been constantly evaluated on its progress in complex generics and the series of M&A transactions done, particularly in the last five years. While the recent ramp...

  • PRO Panorama

    Moneycontrol Pro Panorama | Heading towards capitulation? 

    Sep 27, 2022 / 02:19 PM IST

    In today’s edition of Moneycontrol Pro Panorama: New opportunities and challenges for solar sector, slow GDP likely in India's future, online gaming ecosystem in trouble, what's driving the SME IPO frenzy, and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Fighting the Fed 

    Sep 3, 2022 / 10:06 AM IST

    India is bracing for the ripple effect of the frontloading of rate hikes by the US Fed. The question is, can it have the last laugh

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers